Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Apartment Investment and Management Co (AIV) vs BridgeBio Pharma Inc (BBIO) Price & Performance

Apartment Investment and Management CoTrade
BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

Apartment Investment and Management Co vs BridgeBio Pharma Inc — how do they compare? Apartment Investment and Management Co trades at $2.61 (market cap $376.16M), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is far larger — about 43.5× Apartment Investment and Management Co's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.

AIVBBIO
Market Cap
$376.16M$16.36B
Sector
Real EstateHealth
52-Week High
$7.93$90.17
52-Week Low
$2.59$47.29
Enterprise Value
$738.32M$18.14B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Apartment Investment and Management Co

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment

Read more on AIV

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO